Top AI Companies in Houston, TX (110)

Strong Revenue Growth: Global revenue increased to $60.2B in FY2026, with growth accelerating versus the prior year and all major service lines expanding. Asia Pacific and the Americas contributed most, though expansion was not uniform across regions.

Innovation-Driven Growth: Significant, multi‑billion investments are scaling AI and technology capabilities, alongside large‑scale AI upskilling across the workforce. Initiatives such as AI‑native assurance tools and the PwC One platform indicate a push to embed tech-enabled delivery.

Product Line Growth: New and expanded offerings in technology, consulting, strategy, and tax are being built through acquisitions and strategic investments. Within the latest year, Tax and Legal led growth, with Advisory and Assurance also advancing.

Strong Revenue Growth: Revenue momentum is reflected in ARR rising from $100 million to over $200 million within roughly six months after an under-18-month climb to the first $100 million.

Investor Backing & Capital Strength: Recent financing includes a $550 million Series E at an $8.8 billion valuation, a sharp step-up from earlier 2026 rounds. This signals ample resources to fund continued expansion.

Market Expansion: Operations span 80+ markets with the United States becoming the largest revenue market and more than half of AmLaw 50 firms as customers. Headcount surpassed 1,000 across 18 offices, supporting international scaling.

Strong Revenue Growth: Recent results indicate sales are rising sharply, with fiscal Q3 2026 revenue increasing significantly year over year and management lifting its revenue outlook for both FY2026 and FY2027. Growth is broad-based across servers, networking, and the Cloud & AI segment, underscoring strong top-line momentum.

Profitability: Operating performance has strengthened materially, with operating profit up sharply and margins expanding in the latest quarter. Guidance points to continued non-GAAP earnings growth into FY2027, suggesting improved earnings durability.

Healthy Cash Flow: Cash generation is strengthening, with free cash flow rising to about $1.0B in the latest quarter. The outlook targets at least $5B of free cash flow in FY2027, signaling robust internal funding capacity.

Profitability: Operating earnings and margins improved notably in 2026, with Q3 operating earnings up sharply year over year and the operating margin rising to 5.6%. Feedback suggests earnings resilience is being supported by operational changes and a shifting business mix.

Strong Revenue Growth: Reported annual revenue expanded from $226.6B in 2023 to $270.6B in 2025, including roughly 12% growth in 2024 and 7% in 2025. This establishes a robust multi‑year revenue trajectory even as recent growth rates have moderated.

Cost & Operational Efficiency: Cost controls and operational improvements are described as lifting earnings despite lower revenue in 2026. Optum Health’s operating earnings rose from $41M to $735M year over year while serving fewer value‑based patients, indicating stronger execution.

Investor Backing & Capital Strength: A $31 million Series B in February 2026, bringing reported total funding to about $46 million, indicates strong capital support and plans to scale. Public announcements and independent reporting corroborate the raise and its use for expansion.

Market Expansion: The company states it is moving beyond R&D tax credits into broader U.S. tax and accounting workflows, including areas like 179D deductions and cost segregation. Funding communications explicitly frame the new capital as fuel for this expansion.

Product Line Growth: Positioning now spans R&D credits, 179D deductions, cost segregation, amended returns, and corporate tax returns, signaling a broader offering than its original focus. Partnership activity and integrations further suggest a platform-scale product strategy.

Strong Revenue Growth: Revenue is described as rising at a strong, double‑digit pace across recent quarters and years, with subscription sales increasing alongside total revenue. Company guidance for subscription revenue was raised, reinforcing the momentum.

Resilient & Sustainable Growth: Remaining performance obligations and current contracted revenue expanded, indicating meaningful visibility into future sales. Growth in large enterprise customers and multi‑million‑dollar deals further supports durability.

Innovation-Driven Growth: AI offerings became a meaningful commercial driver as ServiceNow AI exceeded $1 billion in annual contract value and deployments accelerated. Adoption of workflow and AI products is highlighted as a primary catalyst.

Strong Market Position & Advantage: Scale in global asset servicing (roughly $18.6–$20.0 trillion AUC/A) and repeated leadership accolades in custody and U.S. private banking indicate a top‑tier competitive position. The franchise also competes directly with the largest providers even if it typically sits just behind the “big four” in overall custody scale.

Strong Revenue Growth: Recent results show double‑digit year‑over‑year increases in revenue and earnings, with Q2 2026 benefiting from higher fees and net interest income and management raising guidance. Multiple quarters of positive organic trust‑fee growth and expanding client assets (AUC/A and AUM up versus 2025) support momentum.

Diversified Revenue Streams: A fee‑driven mix across asset servicing/custody, wealth/private banking, and asset management underpins durability in varied market conditions. New institutional mandates, capital‑markets strength, and product/capability additions (e.g., ETFs and tokenized‑asset custody) broaden sources of growth.

Strong Market Position & Advantage: Elsevier is widely regarded as a dominant force in STM publishing with flagship journals (e.g., The Lancet, Cell) and critical platforms like ScienceDirect and Scopus. Feedback suggests this entrenched position supports stable demand and reinforces its central role in research and clinical workflows.

Profitability: The business delivers strong profits with high operating margins and contributes materially to its parent company’s earnings. Feedback suggests profitability has remained robust alongside increased article output and heavy platform usage.

Innovation-Driven Growth: The company is shifting toward higher-growth analytics and AI-enabled tools and expanding through targeted healthcare tech acquisitions. Feedback suggests rapid growth in open access output and new AI-assisted research tools positions the business well for future demand.

Resilient & Sustainable Growth: Colleagues are often seen as operating within a business that has maintained a long multi-decade run of annual revenue increases, indicating durability across cycles. The data also points to continued recent year-over-year expansion into 2024–2025, suggesting momentum rather than a one-off spike.

Strong Market Position & Advantage: Colleagues are often seen as benefiting from a top-tier industry position supported by large global scale and frequent placement at or near the top of major industry rankings. The company’s broad footprint and large enterprise client reach are presented as reinforcing competitive advantage in large, complex programs.

Diversified Revenue Streams: Colleagues are often seen as supported by a business mix that extends beyond core translation into technology licensing, AI/data services, legal/eDiscovery, media, and contact-center offerings. The narrative indicates that growth in these adjacent lines is helping offset softness in traditional translation activity.

Profitability: Recent results show a restored GAAP profitability streak through 2025 into 2026, with guidance pointing to higher full‑year earnings. Management highlights healthier unit economics supported by credit normalization.

Cost & Operational Efficiency: Updates describe lower funding costs, expense reductions, and deleveraging steps that improved operating leverage. This cost discipline underpins margin expansion even under a tighter credit posture.

Product Line Growth: Secured personal loans are expanding within the mix and are highlighted as carrying materially lower losses and larger ticket sizes than unsecured loans. This product shift is positioned as a differentiator for higher‑ticket needs in its target segment.